I
n probably the best-known finding from the Women's Health Initiative, postmenopausal hormone therapy with estrogen and progestin was linked to a substantial increase in breast cancer risk. Now researchers think that the increase may be explained by an associated rise in breast density.
Among women taking hormone therapy in the large, prospective women's health study, both the density found on baseline mammograms and the change in density were statistically signifi cantly associated with breast cancer risk, according to Celia Byrne, Ph.D., assistant professor at Georgetown University's Lombardi Comprehensive Cancer Center. Byrne discussed the results of this new analysis of Women's Health Initiative data at the 2010 American Association of Cancer Research meeting in April.
Researchers now consider mammographic density -the amount of white, radiodense area compared with the amount of gray, radiolucent area on a mammogram -one of the strongest independent risk factors for breast cancer ( see "Breast Density Gains Acceptance as Breast Cancer Risk Factor," J. Natl. Cancer Inst. 2010; 102:374 -5 Breast density is a heritable factor, and girls with dense breasts have higher density as women, Boyd and others have shown. According to Boyd's proposed model of risk, cumulative "exposure" to density is an important determinant of breast cancer incidence.
The risk for breast cancer associated with mammographic density may be explained, he said, by the combined effects of mitogens and mutagens. Mitogens, such as human growth hormone and insulin-like growth factor 1 (IGF-1), cause cell proliferation, whereas mutagens, such as radiation, cause genetic damage to proliferating cells.
In a recent study of hormones and growth factors, Boyd's team found that, after accounting for a variety of factors, only human growth hormone was statistically significantly associated with density. But other research suggests that blood levels of IGF-1 are associated with greater cancer risk. IGF-1 is a known mitogen for breast epithelium, which the breast stroma and the liver produce in response to growth hormone. Rulla Tamimi, Sc.D., of Harvard Medical School has compared common genetic variations in the IGF-1 gene and found that certain variants are associated with increased density. The hormone prolactin, which increases breast cell proliferation and reduced apoptosis, or programmed cell death, has also been correlated with breast density in postmenopausal women. Also, urinary levels of malondialdehyde, a marker of oxidative stress and a mutagen, have been correlated with dense breast tissue, as have genetic polymorphisms of certain antioxidant enzymes and IGF-1.
Stroma, Collagen, and Density
Other studies veer away from genetic and hormonal factors and focus on interaction among epithelial cells, fi broblasts, adipocytes (fat cells), and the breast microenvironment. In this camp, researchers are examining the mechanical effect of tissue rigidity, or stiffness, on epithelial cells, on surrounding stroma, and on stromalepithelial interactions.
"While transformation of breast epithelial cells is necessary for breast cancer, stroma surrounding them has been suspected to be involved in epithelial transformation," said Provenzano. Tumors must access fi broblasts, infl ammatory cells, and other cells to form stroma in order to grow.
Some researchers in this area are scrutinizing increased levels of collagen, produced by stroma and a hallmark of dense breast tissue. While at the University of WisconsinMadison, Provenzano investigated a causal connection among dense tissue, stroma, and breast cancer; to do so, he fi rst tried to determine whether increased collagen density could directly promote growth of mammary epithelial cells without stromal cells. He cultured human mammary cells within 3-dimensional collagen gels and measured proliferation. The cells cultured in lowdensity matrices formed well-differentiated structures, as in normal tissue. But those that formed in high-density collagen matrices were larger, less organized, and marked by cellular proliferation, similar to cancerous tissue. This study appeared in 2008 in BioMed Central Medicine .
Provenzano then took live images of tumor -stroma interactions in transgenic mice bred to have more collagen in their mammary glands. Using multiphoton laserscanning microscopy, he found that tissue with more stromal collagen increased tumor formation threefold and resulted in a more invasive cancer with about three times more metastases to the lung. He also saw that stromal collagen facilitated local invasion. Mice with more stromal collagen had increased mammary tumors, and these were more metastatic and invasive.
Tumor growth increases collagen production, so inhibiting collagen synthesis is one possible therapeutic approach to density, according to Thea Tlsty, Ph.D., professor of pathology at the University of California, San Francisco. "Type I collagen is an important binding protein for a wide variety of growth factors that infl uence carcinogenesis," Tlsty said. That means that targeting collagen metabolism might be a way to reduce density and breast cancer risk.
In a study looking at the role of epithelial -stroma l interaction, Tlsty noted that epithelial cells may initiate incorrect stromal signaling, whereas stromal cells -in response to a local stress -can signal to local epithelial cells to proliferate or move into a new developmental pathway. Fibroblasts, which produce collagen, may produce abnormal or fi brotic stroma even before epithelial changes occur.
And in new, unpublished research, Tlsty identifi ed a gene that controls the process by which fi broblasts normally become adipocytes. "If this gene is defective, however, the cells develop along a different, abnormal pathway, and become stromal cells," she said. So normal breast development means more fat and epithelial cells and fewer fi broblasts, stroma, and collagen. Dense breasts consist largely of stromal cells, which deposit more collagen into the microenvironment, stretching and stiffening cells and tissues and setting off mechanosensory signaling, increasing cell proliferation and transformation, Tlsty said.
Increased collagen density may result from one of two mechanisms, according to Provenzano. First may be the infl uence of increased stromal collagen on breast fi broblasts, which in turn infl uence epithelial cells. Stromal fi broblasts can regulate epithelial cells through growth factors and chemokines such as transforming growth factor ␤ , epidermal growth factor receptor, and IGF-1, all implicated in tumorigenesis and metastasis, he said. Higher density is also associated with stiffer extracellular matrix, which alters signaling; increases cell proliferation; and produces a less normal, more cancerous cell type.
Tissue Stiffness
To explore the link between density and the extracellular matrix, Provenzano tested whether higher collagen matrix density, or tissue stiffness, could promote cell proliferation and invasion without stromal cells. According to Weaver, LOX causes many structural changes in collagen through a process called cross-linking. High LOX levels in mammary glands increase collagen cross-linking, making tissue stiffer, and they correlate with a higher incidence of tumor invasiveness. Cross-linking also enhances integrin signaling, which is tied to tumor progression. Weaver, however, believes that the cross-linking of collagen, not its quantity, is the key to breast density and cancer risk.
"My gut says that mammographic density is going to be tricky and complicated with respect to understanding whether or not it is stiffer and if that stiffness could contribute to increased susceptibility to cancer," she said.
Weaver is now measuring breast tissue of women with dense and nondense breasts with atomic-force microscopy, coupled with a comprehensive analysis of crosslinking status of matrix gene profi les, mechanosignaling data, and other criteria, including infl ammation markers.
"We anticipate that we should have at least some indication of what defi nes density in a few years," she said. "But until then, my belief is that all folks who claim that they are modeling breast density when they study the effect of increased collagen concentration on cell behavior ex vivo are overinterpreting and extending data that are not yet conclusive."
